148 related articles for article (PubMed ID: 26770508)
21. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
Laba P; Wang J; Zhang J
BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
[TBL] [Abstract][Full Text] [Related]
22. High expression of Aldolase A predicts poor survival in patients with clear-cell renal cell carcinoma.
Na N; Li H; Xu C; Miao B; Hong L; Huang Z; Jiang Q
Ther Clin Risk Manag; 2017; 13():279-285. PubMed ID: 28280347
[TBL] [Abstract][Full Text] [Related]
23. Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.
Jiang HM; Wei JH; Zhang ZL; Fang Y; Zhou BF; Chen ZH; Lu J; Liao B; Zhou FJ; Luo JH; Chen W
Int Urol Nephrol; 2016 Feb; 48(2):191-9. PubMed ID: 26589610
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of FZD1 is Associated with a Good Prognosis and Resistance of Sunitinib in Clear Cell Renal Cell Carcinoma.
Peng Q; Wang L; Zhao D; Lv Y; Wang H; Chen G; Wang J; Xu W
J Cancer; 2019; 10(5):1237-1251. PubMed ID: 30854133
[TBL] [Abstract][Full Text] [Related]
25. Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma.
Zhang J; Xu X; Chen Z; Zhu Z; Hou J
Evid Based Complement Alternat Med; 2022; 2022():6886590. PubMed ID: 36124013
[TBL] [Abstract][Full Text] [Related]
26. Expression of Opa interacting protein 5 (OIP5) is associated with tumor stage and prognosis of clear cell renal cell carcinoma.
Gong M; Xu Y; Dong W; Guo G; Ni W; Wang Y; Wang Y; An R
Acta Histochem; 2013 Oct; 115(8):810-5. PubMed ID: 23664661
[TBL] [Abstract][Full Text] [Related]
27. High expression of pituitary tumor-transforming gene-1 predicts poor prognosis in clear cell renal cell carcinoma.
Wei C; Yang X; Xi J; Wu W; Yang Z; Wang W; Tang Z; Ying Q; Zhang Y
Mol Clin Oncol; 2015 Mar; 3(2):387-391. PubMed ID: 25798272
[TBL] [Abstract][Full Text] [Related]
28. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of tumor-derived IL-1β and IL-18 in localized renal cell carcinoma: Associations with recurrence and survival.
Xu L; Zhu Y; An H; Liu Y; Lin Z; Wang G; Xu J
Urol Oncol; 2015 Feb; 33(2):68.e9-16. PubMed ID: 25241276
[TBL] [Abstract][Full Text] [Related]
30. Low NR3C2 levels correlate with aggressive features and poor prognosis in non-distant metastatic clear-cell renal cell carcinoma.
Zhao Z; Zhang M; Duan X; Deng T; Qiu H; Zeng G
J Cell Physiol; 2018 Oct; 233(10):6825-6838. PubMed ID: 29693713
[TBL] [Abstract][Full Text] [Related]
31. Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma.
Fu H; Liu Y; Xu L; Liu W; Fu Q; Liu H; Zhang W; Xu J
Tumour Biol; 2015 Aug; 36(8):5791-9. PubMed ID: 25716202
[TBL] [Abstract][Full Text] [Related]
32. Serum level of interleukin-35 as a potential prognostic factor for gastric cancer.
Gu JH; Wang XG; Wang LQ; Zhou LN; Tang M; Li P; Wu XY; Chen MB; Zhang Y
Asia Pac J Clin Oncol; 2021 Feb; 17(1):52-59. PubMed ID: 33044052
[TBL] [Abstract][Full Text] [Related]
33. Low Expression of ATM Indicates a Poor Prognosis in Clear Cell Renal Cell Carcinoma.
Ren W; Xue B; Chen M; Liu L; Zu X
Clin Genitourin Cancer; 2019 Jun; 17(3):e433-e439. PubMed ID: 30773312
[TBL] [Abstract][Full Text] [Related]
34. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation of CRB3 is a prognostic biomarker in clear cell renal cell carcinoma.
Li P; Liu J; Li J; Liu P
Mol Biol Rep; 2019 Aug; 46(4):4377-4383. PubMed ID: 31147860
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.
Xu GH; Lou N; Shi HC; Xu YC; Ruan HL; Xiao W; Liu L; Li X; Xiao HB; Qiu B; Bao L; Yuan CF; Zhou YL; Hu WJ; Chen K; Yang HM; Zhang XP
BMC Cancer; 2018 Jan; 18(1):88. PubMed ID: 29357836
[TBL] [Abstract][Full Text] [Related]
37. Significance of amyloid A immunoexpression in the prognosis of renal cell carcinoma.
Oz Atalay F; Aytac Vuruskan B; Vuruskan H
APMIS; 2016 Apr; 124(4):257-62. PubMed ID: 26750935
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of circWWC3 as a novel survival‑related biomarker for clear cell renal cell carcinoma.
Wang H; Ma X; Li S; Ni X
Oncol Lett; 2023 May; 25(5):196. PubMed ID: 37113397
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma.
Yuan J; Liu S; Yu Q; Lin Y; Bi Y; Wang Y; An R
Acta Histochem; 2013 Jun; 115(5):470-4. PubMed ID: 23245688
[TBL] [Abstract][Full Text] [Related]
40. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]